This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Takeda Pharmaceuticals U.s.a., Inc.. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: The Innovative Contributions of Vijay Gupte in Pharmaceutical Research
Introduction: Vijay Gupte is a notable inventor located in Vernon Hills, IL, USA, contributing significantly to the field of pharmaceutical research. With a total of two patents to his name, Gupte has made strides in developing effective dosage forms for important inhibitors.
Latest Patents: Gupte's latest patents focus on "Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors". The present disclosures reveal novel dosage forms aimed at enhancing the therapeutic efficacy of these inhibitors, showcasing his innovative approach to pharmaceutical formulations.
Career Highlights: Currently, Vijay Gupte works at Takeda Pharmaceuticals U.S.A., Inc., where he applies his expertise in medicinal chemistry and in the development of pharmaceutical products. His work is instrumental in addressing medical needs through innovative drug formulations.
Collaborations: Throughout his career, Gupte has collaborated with esteemed colleagues like Rajneesh Taneja and Majid Vakilynejad. These partnerships underscore the collaborative nature of research and development in the pharmaceutical sector, allowing for the pooling of ideas and expertise.
Conclusion: Vijay Gupte stands as a prominent figure in the realm of pharmaceutical innovations, particularly through his work on modified release dosage forms. His contributions not only reflect his dedication to research but also his potential to impact the future of medicine significantly. With a focus on enhancing the effectiveness of treatments, Gupte's inventive spirit continues to drive progress in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile